- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 10 residues within 4Å:- Chain A: Y.1177, I.1224, F.1225, V.1228
- Chain B: W.1325, L.1326, F.1329, L.1330
- Ligands: POV.18, POV.19
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.1326, B:F.1329, B:L.1330, A:I.1224, A:F.1225, A:F.1225
- Hydrogen bonds: A:Y.1177
CLR.23: 10 residues within 4Å:- Chain B: Y.1177, I.1224, F.1225, V.1228
- Chain C: W.1325, L.1326, F.1329, L.1330
- Ligands: POV.34, POV.35
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:I.1224, B:F.1225, B:F.1225, C:L.1326, C:F.1329, C:L.1330
- Hydrogen bonds: B:Y.1177
CLR.39: 10 residues within 4Å:- Chain C: Y.1177, I.1224, F.1225, V.1228
- Chain D: W.1325, L.1326, F.1329, L.1330
- Ligands: POV.52, POV.53
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:I.1224, C:F.1225, C:F.1225, D:L.1326, D:F.1329, D:L.1330
- Hydrogen bonds: C:Y.1177
CLR.57: 9 residues within 4Å:- Chain A: W.1325, L.1326, L.1330
- Chain D: Y.1177, I.1224, F.1225, V.1228
- Ligands: POV.15, POV.16
8 PLIP interactions:4 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:I.1224, D:F.1225, D:F.1225, A:W.1325, A:W.1325, A:L.1326, A:L.1330
- Hydrogen bonds: D:Y.1177
- 4 x M05: 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium
M05.12: 14 residues within 4Å:- Chain A: S.1175, D.1176, Y.1177, F.1178, D.1232, A.1235, V.1236, M.1245, W.1365, Q.1368, R.1369, F.1372
- Ligands: POV.1, POV.6
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.1178, A:A.1235, A:V.1236, A:F.1372
- Hydrogen bonds: A:Y.1177, A:D.1232
M05.31: 13 residues within 4Å:- Chain B: S.1175, D.1176, Y.1177, F.1178, D.1232, A.1235, M.1245, W.1365, Q.1368, R.1369, F.1372
- Ligands: POV.20, POV.25
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.1178, B:A.1235, B:Q.1368, B:F.1372
- Hydrogen bonds: B:Y.1177, B:D.1232
M05.47: 13 residues within 4Å:- Chain C: S.1175, D.1176, Y.1177, F.1178, D.1232, A.1235, M.1245, W.1365, Q.1368, R.1369, F.1372
- Ligands: POV.36, POV.41
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:F.1178, C:A.1235, C:Q.1368, C:F.1372
- Hydrogen bonds: C:Y.1177, C:D.1232
M05.65: 13 residues within 4Å:- Chain D: S.1175, D.1176, Y.1177, F.1178, D.1232, A.1235, M.1245, W.1365, Q.1368, R.1369, F.1372
- Ligands: POV.54, POV.59
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:F.1178, D:A.1235, D:Q.1368, D:F.1372
- Hydrogen bonds: D:Y.1177, D:D.1232
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.14: 9 residues within 4Å:- Chain A: M.1122, T.1125
- Chain B: P.1282, S.1283, W.1284, I.1290
- Ligands: POV.10, POV.30, POV.35
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.1284, B:I.1290
DU0.33: 10 residues within 4Å:- Chain B: M.1122, T.1125, F.1126
- Chain C: P.1282, S.1283, W.1284, I.1290
- Ligands: POV.29, POV.46, POV.53
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:T.1125, B:F.1126, C:W.1284, C:I.1290
DU0.49: 10 residues within 4Å:- Chain C: M.1122, T.1125, F.1126
- Chain D: P.1282, S.1283, W.1284, I.1290
- Ligands: POV.16, POV.45, POV.64
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:W.1284, D:I.1290, C:F.1126
DU0.51: 8 residues within 4Å:- Chain A: P.1282, S.1283, W.1284, I.1290
- Chain D: M.1122, T.1125
- Ligands: POV.11, POV.19
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:W.1284, A:I.1290, D:T.1125
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural basis of selective TRPM7 inhibition by the anticancer agent CCT128930. Cell Rep (2024)
- Release Date
- 2024-04-17
- Peptides
- Green fluorescent protein,Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 4 x M05: 4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium
- 4 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural basis of selective TRPM7 inhibition by the anticancer agent CCT128930. Cell Rep (2024)
- Release Date
- 2024-04-17
- Peptides
- Green fluorescent protein,Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.